当前位置: 首页 >> 检索结果
共有 16822 条符合本次的查询结果, 用时 6.0381274 秒

1421. Mobilising the health community to protect health care from attack.

作者: Martin Chalfie.;Leonard Rubenstein.;Lujain Alqodmani.;Georges C Benjamin.;Pamela F Cipriano.;Carlos Del Rio.;Victor J Dzau.;Timothy Johnson.;Robert S Lawrence.;Michele Heisler.
来源: Lancet. 2024年404卷10470期2399-2402页

1422. Mexico Summit 20 years on-gains and challenges.

作者: Tikki Pang.;Ulysses Panisset.;Francisco Becerra-Posada.;Julio Frenk.
来源: Lancet. 2024年404卷10466期1903-1905页

1423. Betibeglogene autotemcel gene therapy in patients with transfusion-dependent, severe genotype β-thalassaemia (HGB-212): a non-randomised, multicentre, single-arm, open-label, single-dose, phase 3 trial.

作者: Janet L Kwiatkowski.;Mark C Walters.;Suradej Hongeng.;Evangelia Yannaki.;Andreas E Kulozik.;Joachim B Kunz.;Martin G Sauer.;Adrian J Thrasher.;Isabelle Thuret.;Ashutosh Lal.;Ge Tao.;Shamshad Ali.;Himal L Thakar.;Heidi Elliot.;Ankit Lodaya.;Ji Lee.;Richard A Colvin.;Franco Locatelli.;Alexis A Thompson.
来源: Lancet. 2024年404卷10468期2175-2186页
Transfusion-dependent β-thalassaemia (TDT) is a severe disease, resulting in lifelong blood transfusions, iron overload, and associated complications. Betibeglogene autotemcel (beti-cel) gene therapy uses autologous haematopoietic stem and progenitor cells (HSPCs) transduced with BB305 lentiviral vector to enable transfusion independence.

1424. Japan's lonely deaths: a social epidemic.

作者: Megan Tatum.
来源: Lancet. 2024年404卷10467期2034-2035页

1425. Induced pluripotent stem-cell-derived corneal epithelium for transplant surgery: a single-arm, open-label, first-in-human interventional study in Japan.

作者: Takeshi Soma.;Yoshinori Oie.;Hiroshi Takayanagi.;Shoko Matsubara.;Tomomi Yamada.;Masaki Nomura.;Yu Yoshinaga.;Kazuichi Maruyama.;Atsushi Watanabe.;Kayo Takashima.;Zaixing Mao.;Andrew J Quantock.;Ryuhei Hayashi.;Kohji Nishida.
来源: Lancet. 2024年404卷10466期1929-1939页
The loss of corneal epithelial stem cells from the limbus at the edge of the cornea has severe consequences for vision, with the pathological manifestations of a limbal stem-cell deficiency (LSCD) difficult to treat. Here, to the best of our knowledge, we report the world's first use of corneal epithelial cell sheets derived from human induced pluripotent stem cells (iPSCs) to treat LSCD.

1426. Identifying groups with the greatest need for interventions to improve wellbeing.

作者: Farah Allouch.;Katherine T Mills.
来源: Lancet. 2024年404卷10469期2239-2241页

1427. Disparities in wellbeing in the USA by race and ethnicity, age, sex, and location, 2008-21: an analysis using the Human Development Index.

作者: Laura Dwyer-Lindgren.;Parkes Kendrick.;Mathew M Baumann.;Zhuochen Li.;Chris Schmidt.;Dillon O Sylte.;Farah Daoud.;Wichada La Motte-Kerr.;Robert W Aldridge.;Catherine Bisignano.;Simon I Hay.;Ali H Mokdad.;Christopher J L Murray.
来源: Lancet. 2024年404卷10469期2261-2277页
The Human Development Index (HDI)-a composite metric encompassing a population's life expectancy, education, and income-is used widely for assessing and comparing human development and wellbeing at the country level, but does not account for within-country inequality. In this study of the USA, we aimed to adapt the HDI framework to measure the HDI at an individual level to examine disparities in the distribution of wellbeing by race and ethnicity, sex, age, and geographical location.

1428. Opening the door to widespread iPSC-derived regenerative therapy for corneal epithelial opacity.

作者: Yasuhiko Hirami.;Michiko Mandai.
来源: Lancet. 2024年404卷10466期1898-1899页

1429. Addressing transnational exploitation and armed conflict in the response to mpox.

作者: Jirair Ratevosian.;Michele Heisler.;Tom Carpino.;Thomas McHale.;Joyeux Mushekuru.;Chris Beyrer.
来源: Lancet. 2024年404卷10468期2137-2140页

1430. Jeffrey Stuart Weber.

作者: Geoff Watts.
来源: Lancet. 2024年404卷10465期1806页

1431. Fears for Georgia's NGOs.

作者: Sharmila Devi.
来源: Lancet. 2024年404卷10465期1799页

1432. New HIV drugs: access debates.

作者: Sophie Cousins.
来源: Lancet. 2024年404卷10465期1797-1798页

1433. Intravascular large B-cell lymphoma presenting with non-occlusive mesenteric ischaemia.

作者: Kimihiko Nakamura.;Toru Inoue.;Atsushi Takada.
来源: Lancet. 2024年404卷10465期e5页

1435. Treatment of vulnerable atherosclerotic plaques: the PREVENT trial.

作者: Ioannis Merinopoulos.;Simon C Eccleshall.;Vassilios S Vassiliou.
来源: Lancet. 2024年404卷10465期1813页

1436. Treatment of vulnerable atherosclerotic plaques: the PREVENT trial - Authors' reply.

作者: Seung-Jung Park.;Jung-Min Ahn.;Do-Yoon Kang.;Duk-Woo Park.
来源: Lancet. 2024年404卷10465期1813-1814页

1437. Treatment of vulnerable atherosclerotic plaques: the PREVENT trial.

作者: Shichu Liang.;Junyan Zhang.;Zhongxiu Chen.;Hua Wang.;Yong He.
来源: Lancet. 2024年404卷10465期1812-1813页

1438. Treatment of vulnerable atherosclerotic plaques: the PREVENT trial.

作者: Kyriakos Dimitriadis.;Nikolaos Pyrpyris.;Konstantinos Tsioufis.
来源: Lancet. 2024年404卷10465期1811页

1439. Treatment of vulnerable atherosclerotic plaques: the PREVENT trial.

作者: Chinmay Khandkar.;Jordan Fulcher.;Sanjay Patel.;Anthony Keech.
来源: Lancet. 2024年404卷10465期1811-1812页

1440. Treatment of vulnerable atherosclerotic plaques: the PREVENT trial.

作者: Giuseppe Ferrante.;Gianluca Mincione.;Antonio Colombo.
来源: Lancet. 2024年404卷10465期1810-1811页
共有 16822 条符合本次的查询结果, 用时 6.0381274 秒